Evidence map›Paper›PMID 29713848›Full record

ArticleJournal of neuro-oncology2018

GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.

Shishuang Wu, Jiale Fu, Yu Dong, Qinghao Yi, Dong Lu, Weibing Wang, Yanhua Qi, Rutong Yu, Xiuping Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. The highly expressedJournal of gastrointestinal oncology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. MiR-3150b-3p inhibits the progression of colorectal cancer cells via targeting GOLPH3.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2020
    Article
  18. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shishuang WuThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Jiale FuThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Yu DongThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Qinghao YiThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Dong LuInstitute of Nervous System Diseases, Xuzhou Medical University, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China.
Weibing WangThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Yanhua QiThe Graduate School, Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.
Rutong YuInstitute of Nervous System Diseases, Xuzhou Medical University, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China. yu.rutong@163.com.
Xiuping ZhouInstitute of Nervous System Diseases, Xuzhou Medical University, 84 West Huai-hai Road, Xuzhou, 221002, Jiangsu, People's Republic of China. xpzhou@xzhmu.edu.cn.ORCID http://orcid.org/0000-0002-6663-8168
Xuzhou Medical College · CN

Funding

National Natural Science Foundation of China 81472345National Natural Science Foundation of China 81672489Six major talent summit of Jiangsu Province WSW-039
6 · The paper itself

Abstract

introductionOur recent work reported that GOLPH3 promotes glioma progression via inhibiting endocytosis and degradation of EGFR. The current study aimed to explore the potential regulating mechanism of GOLPH3 on JAK2-STAT3 signaling, a downstream effector of EGFR, in glioma progression.

methodsThe expression of JAK2, STAT3 and GOLPH3 in glioma tissues was detected by western blotting, tissue microarray and immunohistochemistry. The U251 and U87 cells with GOLPH3 down-regulation or over-expression were generated by lentivirus system. The effects of GOLPH3 on the activity of JAK2 and STAT3 were detected by western blotting and reverse transcription polymerase chain reaction. Co-immunoprecipitation was used to detect the association of GOLPH3 with JAK2 and STAT3. Cell proliferation was detected by CCK8 and EdU assay.

resultsThe level of JAK2, STAT3 and GOLPH3 were significantly up-regulated and exhibited pairwise correlation in human glioma tissues. The level of p-JAK2 and p-STAT3, as well as the mRNA and protein levels of cyclin D1 and c-myc, two target genes of STAT3, decreased after GOLPH3 down-regulation, while they increased after GOLPH3 over-expression both in U251 and U87 cells. Interestingly, GOLPH3, JAK2 and STAT3 existed in the same protein complex and GOLPH3 affected the interaction of JAK2 and STAT3. Importantly, down-regulation of STAT3 partially abolished cell proliferation induced by GOLPH3 over-expression.

conclusionsGOLPH3 may act as a scaffold protein to regulate JAK2-STAT3 interaction and then its activation, which therefore mediates the effect of GOLPH3 on cell proliferation.

Indexed as

BrainBrain NeoplasmsCell Line, TumorCell ProliferationDisease ProgressionGene Expression Regulation, NeoplasticGliomaHumansJanus Kinase 2Membrane ProteinsRNA, MessengerSignal TransductionSTAT3 Transcription FactorGOLPH3 protein, humanJAK2 protein, humanJanus Kinase 2Membrane ProteinsRNA, MessengerSTAT3 Transcription FactorGliomaGOLPH3JAK2ProliferationSTAT3

Identifiers

PMID29713848
OpenAlexW2802436983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.